| Novo Nordisk Pharma AG - NovoSeven 2 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 58693 | | 02 | | NovoSeven 2 mg | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD08 | | Coagulation Factor Viia | | 27.03.2009 | | |
|
| Composition |
| Praeparatio cryodesiccata: eptacogum alfa (activatum) 2 mg, natrii chloridum corresp. natrium 1.84 mg, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, methioninum, saccharum, mannitolum, pro vitro.
Solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 2 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Eptacog Alfa | 2 mg |
| | BAG: Active Agent | Dose |
|---|
| Eptacog Alfa | 2 mg |
| | | | Inactive agents |
|---|
| Calcii Chloridum Dihydricum | | Glycyl-Glycinum | | Mannitol | | Methionine | | Sodium Chloride | | Polysorbatum 80 | | Saccharum |
| |
| Solvens | | | Lyophilisate and solvent | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Eptacog Alfa | 2 mg |
| | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | Set(s) | 1690.88 | 1775.90 | B | SL | No |
|
